Industries > Pharma > Global Tuberculosis Treatment Drugs Market Report 2020-2030

Global Tuberculosis Treatment Drugs Market Report 2020-2030

Forecasts & Analysis of Epidemiology by Regions (United States, Europe, Germany, France, Italy, Spain, UK, Japan & Rest of the World), by Regional Markets (North America, Latin America, Middle East & Africa, Asia & Asia Pacific), Plus Analysis of Leading Nations, by Therapies & Leading Companies in the Tuberculosis Treatment Drugs market

PUBLISHED: 01 April 2020
PAGES: 174
PRODUCT CODE: PHA0733
SUBMARKET: Therapeutic Drugs

Clear
WOOCS 2.2.1
SKU: PHA0733 Categories: , Tags: ,

Tuberculosis (TB) is a major public health concern worldwide, with an estimated 10.0 million cases of tuberculosis in 2019, a number that has been relatively stable in recent years. It is interesting to see how WHO, and global companies have taken steps to end tuberculosis worldwide. The growing number of prevalence cases of Multi-Drug Resistant TB and cases of new and relapsed TB among the population of developing and under developing countries have.

Not only the development from the treatment point of view, but also the new development diagnostic tests will play an important role in shifting the dynamics of the tuberculosis market. More than 23 companies have formed an alliance with institutions in developing markets to support clinical therapeutic developments.

The Tuberculosis Treatment Drugs Market is growing at the noteworthy CAGR of 5.8% with the estimated market size of $1,080 million in 2020. Globally market is registered to grow at the CAGR of 5.8% from 2019 to 2020. Growing needs of anti-tuberculosis drugs, increase in multi drug resistance TB cases, government initiatives towards TB elimination and the increase in the pipeline drugs as well as the vaccines will drive the growth of the TB market from 2020 to 2030. In addition, increase in funding will further boost up the institutes and the companies for research in the high TB burden countries.

The Tuberculosis Treatment Drugs Market Report explains the findings of the research of the Tuberculosis treatment market developments and growth factors which is driving the market. It notes key findings and makes recommendations for action for the companies who are actively participating and involved in the R&D of the tuberculosis therapies.

Global Tuberculosis Treatment Drugs Market Report 2020-2030

• Understand the dynamics of TB market
• Epidemiology Forecast and Analysis Globally and Regionally
• Market Forecast & Analysis by Regions, By Nations, By Therapies & By Companies
• Promising Therapies in the pipeline
• Shift from generics to the effective TB therapies
• WHO initiatives to end Global TB
• Growing demand of effective therapies in developed/ developing countries
• High TB Burden countries and funding appropriations
• Effective Diagnostic Tests recently launched & under development

Leading Companies in the Tuberculosis Drugs Market:
• Johnson & Johnson
• Lupin Limited
• Macleods Pharmaceuticals Limited
• Pfizer
• Otsuka Pharmaceuticals

Buy our report today Global Tuberculosis Treatment Drugs Market Research: Forecasts & Analysis of Epidemiology by Regions (United States, Europe, Germany, France, Italy, Spain, UK, Japan & Rest of the World), by Regional Markets (North America, Latin America, Middle East & Africa, Asia & Asia Pacific), Plus Analysis of Leading Nations, by Therapies & Leading Companies. Avoid missing out by staying informed – order our report now.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Global Tuberculosis Treatment Drugs Market Report 2020-2030


Download sample pages

Complete the form below to download your free sample pages for Global Tuberculosis Treatment Drugs Market Report 2020-2030


Latest Pharma news

Visiongain Publishes Healthcare Cold Chain Logistics Market Report 2020-2030

. The growth of this market is majorly driven by increasing sales of temperature sensitive pharmaceutical products, longer life expectancy and rising geriatric population are some of the prominent factors.

16 September 2020

READ

Visiongain Publishes Vaccines Sales Market Report 2020-2030

Visiongain forecasts a continuing growth in global market, submarket and product sales as human vaccines drive pharmaceutical business sales. New key players and technological progress will enter the industry, leading to an increase in the market size of the world market for human vaccines in general.

14 September 2020

READ

Visiongain Publishes Ophthalmic Ultrasound Systems Market Report 2020-2030

The global ophthalmic ultrasound systems market is driven by factors such as the increasing prevalence of ocular disorders and diseases, adoption of novel ophthalmic technologies, rising focus on research & development, and growing health awareness amongst the population.

09 September 2020

READ

Visiongain Publishes Drug Discovery Outsourcing Market Report 2020-2030

The current COVID-19 pandemic is anticipated to have a minor impact on the overall outsourcing business outlook for global drug discovery. Also, significant growth during the COVID-19 pandemic is expected to be seen in the outsourcing of drugs and medicines needed to treat COVID-19 infections.

07 September 2020

READ

Categories

Category